Ads
related to: paroxetine hcl 20mg paxil- Why REXULTI®?
Learn More About an Rx Treatment
REXULTI® (brexpiprazole).
- Full Prescribing Info
Please See Full Prescribing Info
For REXULTI® (brexpiprazole).
- Taking REXULTI®
Find Information About Taking
REXULTI® (brexpiprazole).
- REXULTI® FAQs
Get Answers to Questions
About REXULTI® (brexpiprazole).
- Why REXULTI®?
Search results
Results From The WOW.Com Content Network
Paroxetine, sold under the brand name Paxil among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class [7] used to treat major depressive disorder, obsessive–compulsive disorder (OCD), panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), generalized anxiety disorder, and premenstrual dysphoric disorder. [7]
Hypomania, [7] [unreliable medical source] [8] [9] [unreliable medical source] may occur in as many as 8% of patients being treated with paroxetine. May be more common in those with bipolar disorder. Asthenia; Weight gain or loss. Usually gain, paroxetine tends to produce more weight gain than other SSRIs. [6]: 58 Confusion; Emotional lability ...
This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.
Paxil – an antidepressant of the SSRI class; Nardil – an antidepressant of the MAOI class used to treat depression; Orap – a typical antipsychotic used to treat tic disorder; Pristiq (desvenlafaxine) – an antidepressant of the SNRI class; Prolixin (fluphenazine) – typical antipsychotic
Paroxetine may produce discontinuation-related symptoms at a greater rate than other SSRIs, though qualitatively similar effects have been reported for all SSRIs. [ 181 ] [ 182 ] Discontinuation effects appear to be less for fluoxetine, perhaps owing to its long half-life and the natural tapering effect associated with its slow clearance from ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...